STATCenter·
STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry
Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
Read at STAT →
Health · 1 sources covering this
STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry
Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/fbfae70133aa6806fbb0133491a994598183be6c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry"></iframe>
